- Home
- SLQT vs ABEO Comparison
SLQT vs ABEO Comparison
Compare SLQT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | ABEO |
|---|---|---|
| Founded | 1999 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.1M | 281.0M |
| IPO Year | 2020 | 1980 |
Fundamental Metrics
Financial Performance| Metric | SLQT | ABEO |
|---|---|---|
| Price | $1.67 | $5.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.88 | ★ $18.20 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 02-09-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $1,563,142,000.00 | $400,000.00 |
| Revenue This Year | $13.00 | N/A |
| Revenue Next Year | $7.65 | $1,589.77 |
| P/E Ratio | ★ N/A | $4.24 |
| Revenue Growth | ★ 13.16 | N/A |
| 52 Week Low | $1.33 | $3.93 |
| 52 Week High | $6.86 | $7.54 |
Technical Indicators
Market Signals| Indicator | SLQT | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 62.38 |
| Support Level | $1.34 | $4.98 |
| Resistance Level | $1.76 | $5.34 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 80.95 | 88.58 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.